Ronan Foley

Identification of Drugs Including a Dopamine Receptor Antagonist that Selectively Target Cancer Stem Cells

Eleftherios Sachlos, Ruth M. Risueño, Sarah Laronde et al. · Cell · 2012 · 452 citations · Full text

Drug Targeting, Medicine, Stem Cell Toxicology +9

Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial

Irwin Walker, Tony Panzarella, Stephen Couban et al. · The Lancet Oncology · 2015 · 354 citations

Unrelated Donors, Anti-thymocyte Globulin, Transplantation +9

Acute myeloid leukaemia disrupts endogenous myelo-erythropoiesis by compromising the adipocyte bone marrow niche

Allison L. Boyd, Jennifer Reid, Kyle R. Salci et al. · Nature Cell Biology · 2017 · 203 citations

Hematological Malignancy, Bone Marrow Failure, Malignant Blood Disorder +8

Identification of Chemotherapy-Induced Leukemic-Regenerating Cells Reveals a Transient Vulnerability of Human AML Recurrence

Allison L. Boyd, Lili Aslostovar, Jennifer Reid et al. · Cancer Cell · 2018 · 168 citations · Full text

Hematological Malignancy, Medicine, Transient Vulnerability +9

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group Report

Paul J. Martin, Daniel J. Weisdorf, Donna Przepiorka et al. · Biology of Blood and Marrow Transplantation · 2006 · 162 citations · Full text

Translational Medicine, Graft-versus-host Disease, Transplantation +14